Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoradiation Plus Induction or Consolidation Chemotherapy in Locally Advanced Rectal Cancer
NCT02008656Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2013
- Primary completion
- Nov 2026
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid, capecitabine in rectal cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 2013; status: active, not recruiting.
02
Drugs
oxaliplatinfluorouracilfolinic acidcapecitabine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02008656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008656.